Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2951
Algoma Steel
ASTL
$454M
| $395K | ﹤0.01% |
57,400
-170,205
| -75% | -$950K |
2022 Q1
13 quarters
|
|
2952
GrafTech
EAF
$238M
| $394K | ﹤0.01% |
40,510
-65,630
| -62% | -$580K |
2025 Q1
1 quarter
|
|
|
ACCS
2953
ACCESS Newswire
ACCS
$17.6M
| $393K | ﹤0.01% |
31,938
-100
| -0.3% | -$964 |
2020 Q2
20 quarters
|
|
2954
Richmond Mutual Bancorp
RMBI
$246M
| $393K | ﹤0.01% |
28,442
+7,900
| +38% | +$106K |
2020 Q4
18 quarters
|
|
2955
Chicago Rivet & Machine Co
CVR
$10.8M
| $391K | ﹤0.01% |
32,010
-700
| -2% | -$8.14K |
2013 Q2
48 quarters
|
|
2956
EuroDry
EDRY
$187M
| $391K | ﹤0.01% |
40,000
-300
| -0.7% | -$2.69K |
2020 Q4
18 quarters
|
|
|
NEUE
2957
DELISTED
NeueHealth
NEUE
| $388K | ﹤0.01% |
56,163
| – | – |
2021 Q4
14 quarters
|
|
2958
Owens Corning
OC
$9.02B
| $385K | ﹤0.01% |
+2,800
| New | +$387K |
2025 Q2
0 quarters
|
|
2959
Spire Global
SPIR
$402M
| $384K | ﹤0.01% |
32,300
-47,800
| -60% | -$482K |
2024 Q4
2 quarters
|
|
2960
LiveOne
LVO
$37M
| $384K | ﹤0.01% |
50,911
+2,400
| +5% | +$17.8K |
2021 Q2
16 quarters
|
|
2961
Rapid Micro Biosystems
RPID
$44.8M
| $383K | ﹤0.01% |
110,987
+400
| +0.4% | +$1.16K |
2023 Q1
9 quarters
|
|
2962
Coherus Oncology
CHRS
$165M
| $382K | ﹤0.01% |
522,925
+12,297
| +2% | +$10.6K |
2025 Q1
1 quarter
|
|
2963
EVgo
EVGO
$173M
| $382K | ﹤0.01% |
+104,700
| New | +$359K |
2025 Q2
0 quarters
|
|
2964
Smart Sand
SND
$224M
| $382K | ﹤0.01% |
190,100
-103,800
| -35% | -$210K |
2021 Q4
14 quarters
|
|
2965
Direxion Daily Regional Banks Bull 3X ETF
DPST
$308M
| $382K | ﹤0.01% |
+4,400
| New | +$324K |
2025 Q2
0 quarters
|
|
2966
Community Bank
CBU
$3.08B
| $381K | ﹤0.01% |
6,708
-5,600
| -45% | -$311K |
2025 Q1
1 quarter
|
|
2967
Aligos Therapeutics
ALGS
$33.3M
| $379K | ﹤0.01% |
52,544
+12,968
| +33% | +$77.6K |
2021 Q3
15 quarters
|
|
2968
Kyverna Therapeutics
KYTX
$395M
| $376K | ﹤0.01% |
122,417
-2,541
| -2% | -$6.29K |
2024 Q4
2 quarters
|
|
2969
KORU Medical Systems
KRMD
$137M
| $374K | ﹤0.01% |
104,600
-99,856
| -49% | -$284K |
2024 Q3
3 quarters
|
|
2970
Century Casinos
CNTY
$24.1M
| $373K | ﹤0.01% |
176,449
+3,300
| +2% | +$5.89K |
2013 Q2
48 quarters
|
|
2971
Vertex
VERX
$2.1B
| $371K | ﹤0.01% |
+10,500
| New | +$400K |
2025 Q2
0 quarters
|
|
2972
Mammoth Energy Services
TUSK
$136M
| $370K | ﹤0.01% |
132,172
-3,100
| -2% | -$7.93K |
2020 Q2
20 quarters
|
|
|
BIOA
2973
BioAge Labs
BIOA
$291M
| $369K | ﹤0.01% |
+89,296
| New | +$360K |
2025 Q2
0 quarters
|
|
|
PLTU
2974
Direxion Daily PLTR Bull 2X ETF
PLTU
$544M
| $369K | ﹤0.01% |
+6,000
| New | +$296K |
2025 Q2
0 quarters
|
|
2975
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.21B
| $366K | ﹤0.01% |
7,700
-35,300
| -82% | -$1.67M |
2024 Q4
2 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.